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Chronic recurrent multifocal osteomyelitis/ chronic non-bacterial osteomyelitis (CRMO/
CNO) is a rare auto-inflammatory disease and typically manifests in terms of musculoskele-
tal pain. Because of a high frequency of musculoskeletal disorders in children/ adolescents,
it can be quite challenging to distinguish CRMO/ CNO from nonspecific musculosketetal
pain or from malignancies. The purpose of this study was to evaluate the visibility of CRMO
lesions in a whole-body diffusion-weighted imaging (WB-DWI) technique and its potential
clinical value to better characterize MR-visible lesions.
Material and Methods
Whole-body imaging at 3T was performed in 16 patients (average: 13 years) with con-
firmed CRMO. The protocol included 2D Short Tau Inversion Recovery (STIR) imaging in
coronal and axial orientation as well as diffusion-weighted imaging in axial orientation. Visi-
bility of lesions in DWI and STIR was evaluated by two readers in consensus. The apparent
diffusion coefficient (ADC) was measured for every lesion and corresponding reference
locations.
Results
A total of 33 lesions (on average 2 per patient) visible in STIR and DWI images (b = 800 s/
mm2 and ADCmaps) were included, predominantly located in the long bones. With a mean
value of 1283 mm2/s in lesions, the ADC was significantly higher than in corresponding ref-
erence regions (782 mm2/s). By calculating the ratio (lesion to reference), 82% of all lesions
showed a relative signal increase of 10% or higher and 76% (25 lesions) showed a signal
increase of more than 15%. The median relative signal increase was 69%.
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Conclusion
This study shows that WB-DWI can be reliably performed in children at 3T and predomi-
nantly, the ADC values were substantially elevated in CRMO lesions. WB-DWI in conjunc-
tion with clinical data is seen as a promising technique to distinguish benign inflammatory
processes (in terms of increased ADC values) from particular malignancies.
Introduction
Chronic recurrent multifocal osteomyelitis / chronic non-bacterial osteomyelitis (CRMO/
CNO) is a rare, auto-inflammatory, non-bacterial disease and was first described by Giedion
et al. in 1972 [1]. The annual incidence is currently estimated at 0.4 per 100 000 in Germany
[2]. To date, etiology and the pathogenesis of CRMO/ CNO are still unknown [3] and there is
no specific test or examination for the disease [4]. Because of a high frequency of musculoskele-
tal disorders in children/ adolescents, it can be quite challenging to distinguish CRMO/ CNO
from nonspecific musculosketetal pain or from malignancies.
Initial clinical symptoms of CRMO/ CNO typically are swelling and severe pain of the
affected bones [2], while multifocality of bone involvement often only occurs during following
episodes of the disease [5–9]. Since clinical symptoms on onset widely overlap with the symp-
toms of malignant bone tumors, e.g. Ewing’s sarkoma, imaging can play an essential role to
exclude malignancy. Furthermore, imaging can help to characterize the disease and to triage
patients to adequate treatment. If diagnosed earlier, complications of CRMO/ CNO (e.g. frac-
ture, vertebra plana) may be prevented.
Compared to other whole body imaging tools like PET or bone scintigraphy [3,5–11],
whole-body MRI (WB-MRI) has been found to be of superior sensitivity in detecting multifo-
cal edematous lesions, which appear as focal or diffuse hyper-intense regions in fat-saturated
T2-weighted images [12]. However, this appearance is non-specific and malignancy can some-
times not be completely ruled out—in uncertain cases, especially in case of unifocal lesions,
biopsy remains mandatory to date.
In this regard, diffusion-weighted imaging has been proposed as a potential means for dif-
ferential diagnosis of inflammatory vs. malignant etiology [11]. Diffusion-weighted imaging
(DWI) measures the self-diffusion of water molecules and can be quantified in terms of the
apparent diffusion coefficient (ADC), which helps to gain information about tissue cellularity
[13]. Malignant lesions often tend to have an increased cellular density which impairs water
diffusion and are therefore associated with diminished ADC while edematous bone-marrow
presents with a high fraction of free inter-cellular water, resulting in an increased diffusion
coefficient.
Nonetheless, studies investigating the clinical value of DWI in children with non-tumorous
lesions / in children with CRMO/ CNO are still rare and only involved locoregional imaging of
diffusion properties [11]. This may be attributed to the fact that technical constraints have
impaired the widespread application of the technique throughout all body regions [14]. Tar-
geted MR imaging, however, cannot be used to assess multifocality. Due to the ongoing evolu-
tion of DWI into a whole-body method (WB-DWI), the present study aims to evaluate the
method for a systemic investigation of bone-marrow lesions. Our aims were to describe the
appearance of CRMO/ CNO in WB-DWI and to evaluate its potential in the classification of
the detected lesions.
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PLOSONE | DOI:10.1371/journal.pone.0147523 January 22, 2016 2 / 12
the authors’ adherence to PLOS ONE policies on
sharing data and materials.
Material and Methods
Patients
The study was approved by the local ethics committee of the Medical Faculty of the University
of Leipzig, written informed consent was obtained from the legal guardians of all patients. The
use of anonymized data for research purposes is included in the treatment contract between
patients and our university hospital. All examinations were conducted between March 2012 –
February 2014 in children with known CRMO/ CNO, to rule out new suspected lesions or to
reevaluate bone marrow edema as a follow-up. In accordance with the classification used by
Fritz et al. [6], initial diagnosis was based on the presence of multifocal, high-signal intensities
in the bone marrow in STIR series in corroboration with clinical findings (good general health,
relatively mild inflammatory syndrome, moderately elevated erythrocyte sedimentation rate).
In case of inconclusive findings, initial diagnosis was made by biopsy.
16 patients (age range 8–17 years; mean age 12.9 years) were included in the study; 11 were
female, 5 were male.
The time between initial diagnosis and MR examination varied substantially. All included
patients received treatment with non-steroidal anti-inflammatory drugs (NSAID), sometimes
for many months before the MR examination included here took place. One patient received
treatment with methotrexate and biologicals as well. For further clinical information please see
Table 1.
MRI examinations
Whole-body measurements were performed in a 3T MR scanner (MAGNETOM Tim Trio,
Siemens Healthcare, Erlangen, Germany) equipped with a multi stational moving table option,
using a multichannel surface coil system (Total Imaging Matrix) and employing parallel imag-
ing technology (iPAT). Thoracic imaging was breath-triggered using a breathing-belt while
patients breathed spontaneously. The entire examination, including patient preparation, posi-
tioning and scanning took approximately 60–70 minutes in total to complete.
Table 1. Clinical baseline data of the included patients. Abbreviations: m (male); f (female); NSAID (non-steroidal anti-inflammatory drugs); Y (Yes); N
(No).
Sex Age on onset Age (MR Exam) Time between onset and follow-up MRI (months) Medication Biopsy
m 13 15 26 NSAID Y
f 10 12 28 NSAID Y
f 10 12 32 NSAID Y
f 9 15 71 NSAID N
m 14 16 23 NSAID N
f 8 8 1 NSAID Y
f 9 9 1 NSAID N
f 11 12 15 NSAID N
f 12 13 15 NSAID N
m 12 12 2 NSAID N
f 8 17 19 NSAID N
f 14 14 11 NSAID Y
f 12 12 9 NSAID N
m 10 10 3 NSAID N
m 11 16 65 NSAID, Methotrexate, Biologicals Y
f 9 12 47 NSAID Y
doi:10.1371/journal.pone.0147523.t001
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In our standard scan protocol we used axial and coronal 2D short Tau inversion recovery
(STIR) images and axial DWI. Imaging parameters for STIR were as follows: Repetition
Time / Echo Time (TR/TE) = 4300–4600 ms / 49 ms; Inversion Time (TI) = 220 ms,
flip angle = 150°, Field of View (FoV) = (500x500) mm, Matrix (MX) = 448x336, Voxel
Size = 1.1 x 1.5 mm, Slice Thickness = 5 mm, 1 average. We used inversion recovery because
it enables a more robust fat suppression over large fields-of-view than spectral fat suppression
techniques.
Axial isotropic diffusion-weighted images (DWI) from head to feet were acquired using
b-values of 50 s/mm2 and of 800 s/mm2, with a slice thickness of 4 mm. Whole-body coverage
was usually achieved in 6–8 continuous stations, dependent on the height of the child, using a
free-breathing technique in the thoracic station. Depending on the number of deployed sta-
tions, DWI scanning took an extra of 12–16 minutes. Scanning parameters for diffusion
weighted series were TR 6100–7200 ms, TE 62 ms, flip angle 90°, fatsat, bandwidth 976 Hz/
pixel, FoV = (500x500) mm, MX = 256x256, Voxel Size = 1.95 x 1.95 mm, 1 average.
The b = 800 s/mm2 images were composed and reconstructed in the coronal plane (5 mm)
and as thick 3D maximum intensity projections (MIPs), which were displayed using an
inverted grey scale for a PET-like image resemblance using the standard inversion feature of
the syngo software. ADC maps were generated automatically with the scanner software, using
mono-exponential fitting.
Image interpretation
Image interpretation was performed by using a postprocessing workstation (syngo, Siemens
Healthcare). Images were evaluated for the presence of focal, high-signal intensity in STIR
series both in axial and coronal views. In accordance to the found positions, b800-images were
evaluated for respective signal alterations. Circular regions of interest (ROIs) were placed in
bone marrow edema and normal tissue on the opposite, normal appearing side (reference
region) to determine the mean ADC (± standard deviation) value for each location. Size of the
ROI was individually adapted to the actual lesion size but lesions with a diameter of less than 5
mm were excluded. This ROI was then copied and subjectively shifted to the corresponding
reference position on the opposite side.
All examinations were evaluated by two readers in consensus. Furthermore, image quality
of DWI scans was rated by applying a 3-point scoring system (0 = non diagnostic; 1 = impaired
quality; 2 = good quality) intending to rule out non-diagnostic scans. The readers had access to
all clinical patient information including age, sex, family history and painful sites.
Results
In whole-body STIR sequences, a total of 38 lesions were detected in our cohort of 16 patients,
resulting in 2 lesions per patient on average. The most commonly affected regions in our
patient cohort were the pelvis/ hip and the lower limbs (see Table 2).
Most lesions appeared as asymmetric, ill- and irregular- defined changes in the bone mar-
row with a hyperintense appearance in STIR images. Foci were typically settled in metaphyseal
and epiphyseal regions adjacent to a growth plate of tubular bones, as well as in the sacrum, the
spine and the pelvis. There was one case of diaphyseal involvement, representing as a huge
lesion with periostal reaction of the left humerus (Fig 1).
DWI
In 2 patients DWI could not be evaluated because of non-diagnostic image quality. Sources of
image quality degradation were motion and ghosting artifacts. In the remaining 14 patients, 33
Whole-Body DWI in Children with CRMO
PLOSONE | DOI:10.1371/journal.pone.0147523 January 22, 2016 4 / 12
lesions were found in DWI which showed corresponding alterations in STIR and were included
in the evaluation. Of these, 25 showed signal alterations in DWI higher than 15% compared to
the contralateral side (Table 3). Lesions seen only in DWI with no matching findings in STIR
were excluded from the evaluation.
Table 2. Location of signal alterations in STIR and DWI (here, only the 25 lesions with a relative ADC
increase of more than 15%were considered).
Localization STIR DWI
Neurocranium - -
Clavicula/ Shouldergirdle 1 1
Humerus 3 3
Radius / Ulna - -
Spine 1 1
Pelvis / Hip 15 10
Femur 3 2
Tibia / Fibula 9 7
Feet 1 1
doi:10.1371/journal.pone.0147523.t002
Fig 1. MR images of 12-year old girl with known CRMO. a) STIR-weighted images show diaphyseal edematous bone marrow involvement, periostal
reaction of the left humerus b) axial series showing large and homogenous bony involvement c) signal alteration in DWI b = 800 images d) ADC increase at
the corresponding site.
doi:10.1371/journal.pone.0147523.g001
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Skeletal edema detected in STIR images showed up as focal or diffuse area of high-signal
intensity on high b-value and also a high ADC-value in WB-DWI (Figs 1–3) in most of our
cases. In comparing the apparent diffusion coefficient value of the signal alteration site and the
values of the corresponding opposite/ healthy side, one can detect that the apparent diffusion
coefficient value of the lesions are relatively higher compared to the healthy side (Table 3). The
mean ADC value in lesions was 1283 mm2/sec, and 782 mm2/sec in corresponding reference
regions (Fig 4). A paired t test revealed a statistically highly significant (p<0.0001) difference
between lesion and reference values (t = 6.638, sample size 32). By calculating the ratio (lesion
to contralateral; see also Table 3), 82% of all lesions showed a relative signal increase of 10% or
higher and 76% showed a signal increase of more than 15%. The median relative signal increase
was 69%.
Table 3. Measured ADC value for lesion, reference regions, the corresponding ratio and location. Abbreviations: Y (Yes); N (No).
# ADC (lesion) ADC (reference region) ADC ratio Localization Symptoms (Pain)
1 1754 ± 442 877 ± 508 2.00 Right clavicula Y
2 1241 ± 307 707 ± 369 1.76 Left humerus N
3 1849 ±144 853 ± 197 2.17 Left tibia Y
4 1513 ± 119 1194 ± 274 1.27 Right tibia N
5 497 ± 125 421 ± 77 1.18 Right pelvis N
6 975 ± 91 577 ± 268 1.69 Left humerus N
7 884 ± 95 587 ± 238 1.51 Right sacrum Y
8 655 ±121 610 ± 71 1.07 Right pelvis N
9 987 ± 255 449 ± 239 2.20 Right foot Y
10 1578 ± 54 559± 115 2.82 Left acetabulum N
11 1272 ± 190 580 ± 44 2.19 Right pelvis Y
12 1528 ± 76 767 ± 221 1.99 Left pelvis N
13 1672 ± 42 402 ± 215 4.16 Right tibia Y
14 1449 ± 218 1112 ± 160 1.30 Left hip Y
15 1755 ± 125 477 ± 185 3.68 Right pelvis Y
16 918 ± 173 460 ± 209 2.00 Right hip N
17 1623 ± 498 1663 ± 315 0.98 Left tibia N
18 1569 ± 252 752 ± 247 2.09 Left humerus Y
19 832 ± 47 620 ± 80 1.34 Left sacrum N
20 768 ± 58 532 ± 61 1.44 Right sacrum N
21 1340 ± 367 1190 ± 584 1.13 Right tibia N
22 1663 ± 138 363 ± 262 4.58 Right sacrum Y
23 1682 ± 160 598 ± 41 2.81 Left femur N
24 1427 ± 12 692 ± 43 2.06 Right femur N
25 891 ± 92 794 ± 121 1.12 Right pelvis N
26 1640 ± 144 715 ± 522 2.29 Right tibia N
27 1680 ± 141 863 ± 262 1.95 Lumbar vertebra 2 Y
28 1642 ± 165 1648 ± 266 1.00 Left knee N
29 949 ± 108 1198 ± 123 0.79 Right tibia N
30 1193 ± 70 940 ± 142 1.27 Left tibia N
31 709 ± 63 720 ± 94 0.98 Right pelvis N
32 1197 ± 137 908 ± 114 1.32 Left tibia N
33 1035 ± 153 1006 ± 104 1.03 Right pelvis N
doi:10.1371/journal.pone.0147523.t003
Whole-Body DWI in Children with CRMO
PLOSONE | DOI:10.1371/journal.pone.0147523 January 22, 2016 6 / 12
Fig 2. “At-a-glance” visualisation of Whole-body-DWI. Intuitive visualisation of Whole-body-DWI with
maximum intensity projection MIP in a 12-year-old girl with multifocal CRMOmanifestations shows signal
alterations on DWI in the left pelvis (Os ilium) and in the right ankle/ distal tibia.
doi:10.1371/journal.pone.0147523.g002
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Discussion
The clinical potential of DWI in children with suspected CRMO/ CNO is to further character-
ize tissue in terms of biologic tissue characteristics rather than morphologic appearance and is
a promising measure to confirm the benignity of multifocal lesions in these children.
Fig 3. Multiparametric MRI. a) contrast-enhancement of a CRMO-lesion in the right Os ilium on axial
T1-TSE FS b) corresponding signal alteration on STIR images c) correlating signal changes on axial DWI
b800 d) and high signal intensity on ADC.
doi:10.1371/journal.pone.0147523.g003
Fig 4. Box-Plot of ADC values. Increased ADC in CRMO-lesions compared to the corresponding reference
regions. Since bone marrow cellularity is highly dependent form lesion location and other individual clinical
factors, absolute ADC values both in affected and normal bone varied substantially, which made the
recommendation of a generalized threshold impossible.
doi:10.1371/journal.pone.0147523.g004
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While previous studies already have shown the clinical utility of DWI for specific body
regions in mixed cohorts of children with different benign-inflammatory and malignant dis-
eases, this study is the first to implement and assess DWI as a whole-body technique in a
cohort of children with the rare auto-inflammatory disease CRMO/ CNO.
From a technical point of view, WB-DWI can be reliably performed in children. The exami-
nation itself requires an extra scan time of approximately 15 minutes. Even though the youn-
gest patient was only 8 years old, none of the patients cancelled the examination due to
positioning discomfort or anxiety because of gradient-associated vibrations and sound pressure
during diffusion-weighted scanning. However, the authors believe that it is an essential prereq-
uisite to perceptively prepare infant patients before the whole-body scan. When reading
WB-DWI series, some general technical aspects should be kept in mind: the detection of skele-
tal edema onWB-DWI may be affected in areas of movement such as the anterior ribs and
sternum [14]. Visibility of skull vault infiltrations can be impaired because of the adjacent high
signal of the normal brain and the visibility of skull base disease is impaired because of suscep-
tibility effects [14]. In our small cohort, no lesion was found in the skull base or in the neuro-
cranium. Furthermore, magnetic field inhomogeneties secondary to metal and air interfaces
(for example bracelets) may induce artifacts that cause false positive or false negative DWI
lesions and at the same time can conceal lesions in the adjacent bones. However, when consid-
ering WB-DWI as an additional examination that is read in association with conventional
morphological WB-MRI sequences (e.g. STIR), false-positive findings can be easily ruled out.
Notwithstanding the non-diagnostic quality of WB-DWI examination in two cases due to
severe ghosting artifacts and motion—without any identifiable shortcoming regarding the con-
duction of the scans—a technical success rate of 90% was considered acceptable/sufficient.
Upcoming techniques such as slice-dependent shim [15] have the potential to overcome these
limitations in the near future.
Clinically, DWI has been already shown to be useful to detect and to further characterize
inflammatory bone marrow lesions in terms of relative changes of cellularity. With growing
water content and increasing grade of inflammation, edematous bone marrow returns higher
signal intensities in STIR sequences and higher ADC values [16–19]. One major challenge in
interpretation of MR scans of the infant skeleton, however, is the signal appearance of bones
in general: The normal adolescent and infant bone marrow pattern shows high signal intensity
in STIR weighted images, especially near the epiphyses and high signal intensities are also
seen in DWI. Conditions that make it more difficult to interpret WB-MRI in children than in
adults.
As it is depicted by the presented results, edematous lesions of the bone marrow tend to
appear as clear and distinct areas of signal alteration in DWI. Since the ability to detect bone
marrow lesions is dependent on the signal intensity of the background bone marrow and sur-
rounding tissues, the superior lesion conspicuity compared to conventional STIR imaging may
be attributed to the faint anatomical background in DWI [11]. Referring to the multifocal
nature of CRMO, the technique may even contribute to diagnosis in terms of easier lesion
detection throughout the body. In unifocal lesions, WB-DWI in conjunction with clinical
data is seen as a promising technique which may help to distinguish benign inflammatory pro-
cesses (in terms of increased ADC values) from early manifestation of particular malignancies.
However, in this study we only included lesions with matching findings in DWI and STIR.
Lesions only visible in DWI were deliberately excluded, since the aim of this study was to
evaluate the potential of DWI to better characterize lesions detected with conventional WB
imaging and not to compare the sensitivity of both parameters. This could be the topic of fur-
ther investigation.
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Previous studies have shown that osteoporotic caused vertebral fractures and fractures
caused by malignant lesions differ significantly when it comes to ADC values, potentially
allowing for a differential diagnosis of benign and malignant entities [13]. In comparison to
bone tumors, which come along with restricted diffusion appearance and a consecutively
diminished ADC value [20], benign inflammatory changes seem to dispose a diffusion alter-
ation which comes along with corresponding high ADC values [16] in most cases. Based on the
presented results, this seems to count for bony changes as well: even though lacking a control
group of patients with malignant changes for comparative purposes, most of all lesions showed
increased ADC values compared to respective reference regions. This seems to be in good
accordance with previous studies, which have investigated musculoskeletal, locoregional DWI
in rheumatological issues [11,21].
However, the relation of bone marrow cellularity and ADC values is highly dependent on
the water, cellular and fat volume of the marrow. Its conversion status is reliant on patient`s
age, gender, the anatomic location and even the treatment status [16]. The relationship in
between these components is non-linear and varies significantly through the different body
regions [16]. For example, (intermediate) high signal intensity is seen normally in the appen-
dicular skeleton, i.e. the femura, marking (mixed) red bone marrow [16]. Accordingly, our
results reveal a substantial variation of the absolute ADC values both in affected and normal
bone. Furtherrmore, it is commonly known that imaging parameters as well as the imaging
hardware may generally affect the results of ADC calculation [22]. To the current point in time
this makes the independent recommendation of an ADC threshold difficult, if not impossible.
The calculation of an ADC ratio, as proposed here, needs further evaluation but might over-
come the mentioned limitations of absolute ADC measurements.
This work had several limitations. First, the number of patients was very limited. This is due
to the fact that it was decided to preserve a homogenous study cohort of CRMO patients only.
Previous studies also suffered from the rare incidence of the disease, with cohorts typically
ranging between 9 and 21 patients [3,6,8]. Second, some of the patients had a long history and
received treatment over years. This could be also a reason for the relatively rare bone marrow
affection in some of our patients, compared to the literature. Furthermore, discrepancies
between the number of lesions visible with STIR and DWI may be attributed to effects of treat-
ment, since effects on the cellular level appear much earlier. In one case, for example, the
patient was treated with NSAID, methotrexate and biologicals and was asymptomatic at the
time of follow-up MRI. Accordingly, no “active” lesions in DWI have been found. In an opti-
mal study setting, WB-DWI would have been performed in a population of newly diagnosed
and/ or untreated patients. Third, WB-DWI at a magnetic field strength of 3T remains chal-
lenging because of less optimal fat suppression and increasing susceptibility artifacts compared
to 1.5T and may have impaired the overall technical success rate. Therefore reading was per-
formed in consensus, which is a further limitation of this study. Last, no further contrasts than
STIR, i.e. T1w contrast-enhanced scans, were acquired in order to keep the follow-up exams
non-invasive. In the setting of follow-up studies/ established CRMO, we actually think that
contrast-enhancing studies are dispensable in general.
However, three out of our patients underwent T1w contrast-enhanced MR examinations
less than a week before the WB-scans. The reported, enhancing areas in T1-weighted fat-sat
contrast-enhanced series corresponded almost perfectly with alterations in the diffusion-
weighted series.
In conclusion, WB-DWI can be reliably performed in children at 3T and predominantly,
the ADC values were substantially elevated in CRMO lesions. WB-DWI in conjunction with
clinical data is seen as a promising technique to distinguish benign inflammatory processes (in
terms of increased ADC values) from particular malignancies.
Whole-Body DWI in Children with CRMO
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